Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Threechada Boonchan"'
Autor:
Bertha Wojnarski, Chanthap Lon, Darapiseth Sea, Somethy Sok, Sabaithip Sriwichai, Soklyda Chann, Sohei Hom, Threechada Boonchan, Sokna Ly, Chandara Sok, Samon Nou, Pheaktra Oung, Nareth Kong, Vannak Pheap, Khengheang Thay, Vy Dao, Worachet Kuntawunginn, Mitra Feldman, Panita Gosi, Nillawan Buathong, Mali Ittiverakul, Nichapat Uthaimongkol, Rekol Huy, Michele Spring, Dysoley Lek, Philip Smith, Mark M Fukuda, Mariusz Wojnarski
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228207 (2020)
BACKGROUND:Primaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate dehydrogenase deficient (G6PDd) patient. There is a need for reliable po
Externí odkaz:
https://doaj.org/article/ef08d2a9d03b4085b8f7f6c4f4c956af
Autor:
Threechada Boonchan
Publikováno v:
Insight Urology. 42:144-153
Objective: To investigate the impact and the incidence of nocturia on the quality of life of patients in Ramathibodi Hospital. Materials and Methods: This study was a hospital-based cross-sectional study to measure the QoL of nocturia patients using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::250dd918a0a4792eeb04aa97468709ae
https://doi.org/10.52786/isu.a.37
https://doi.org/10.52786/isu.a.37
Autor:
Threechada Boonchan, Panita Gosi, Worachet Kuntawunginn, Soklyda Chann, Samon Nou, Rekol Huy, Dysoley Lek, Sabaithip Sriwichai, Nillawan Buathong, Darapiseth Sea, Vy Dao, Somethy Sok, Bertha Wojnarski, Nichapat Uthaimongkol, Mark M. Fukuda, Chanthap Lon, Pheaktra Oung, Michele D. Spring, Nareth Kong, Khengheang Thay, Sohei Hom, Sokna Ly, Mariusz Wojnarski, Mali Ittiverakul, Mitra Feldman, Philip A. Smith, Vannak Pheap, Chandara Sok
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 1, p e0228207 (2020)
PLoS ONE, Vol 15, Iss 1, p e0228207 (2020)
Background Primaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate dehydrogenase deficient (G6PDd) patient. There is a need for reliable po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b82c8c823ab924c57b43918dbfcc87e3
https://pubmed.ncbi.nlm.nih.gov/32004348
https://pubmed.ncbi.nlm.nih.gov/32004348
Autor:
Philip A. Smith, Saowaluk Wongarunkochakorn, Soklyda Chann, Jessica T. Lin, Somethy Sok, Vireak Heang, Worachet Kuntawunginn, Michele D. Spring, Satharath Prom, Andrew Vaughn, Suwanna Chaoratanakawee, Hana Burkly, Threechada Boonchan, Thay Keang Heng, Nareth Kong, Mark M. Fukuda, Dysoley Lek, Agus Rachmat, Catherine M. Berjohn, Pattaraporn Vanachayangkul, Nillawan Buathong, Mali Ittiverakul, Chanthap Lon, Mariusz Wojnarski, Dustin Harrison, Panita Gosi, David L. Saunders, Bolin Chum, Andreea Waltmann
Publikováno v:
Open Forum Infect Dis
Background Recent artemisinin-combination therapy failures in Cambodia prompted a search for alternatives. Atovaquone-proguanil (AP), a safe, effective treatment for multidrug-resistant Plasmodium falciparum (P.f.), previously demonstrated additive e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6f2441a85c522485cbca2c86936e04e
